Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel with or without RAD001 in Advanced Gastric Carcinoma
NCT01248403Phase 3Completed
- Sponsor
- Krankenhaus Nordwest
- Start
- Oct 2011
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gastric cancer (GC) and esophagogastric junction cancer comparing Paclitaxel + Placebo with Paclitaxel + RAD001 (2 arms). Primary endpoint: Overall Survival. Started Oct 2011; status: completed.
02
Drugs
everolimus
03
Conditions
gastric cancer (GC)esophagogastric junction cancer
Beyond the preview
Go deeper on NCT01248403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01248403.